Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

ClinicalTrials.gov ID: NCT02244606

Public ClinicalTrials.gov record NCT02244606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label, Randomized Study to Estimate Safety, PK, and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Standard-of-Care Following IV Echinocandin Therapy in the Treatment of Invasive Candidiasis in Hospitalized Nonneutropenic Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety, pharmacokinetics, and efficacy of oral SCY-078 vs. standard-of-care following initial intravenous echinocandin therapy in the treatment of invasive candidiasis.

Study identification

NCT ID
NCT02244606
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
27 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Type not available)
Primary completion
Jun 2016 (Actual)
Completion
Aug 2016 (Actual)
Last update posted
Jun 25, 2024

2014 – 2016

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
UC Davis Medical Center Sacramento California 95817 —
University of Colorado Denver Aurora Colorado 80045 —
University of Miami Miami Florida 33125 —
Georgia Regents University Augusta Georgia 30912 —
University of Chicago Chicago Illinois 60637 —
Johns Hopkins University School of Medicine Baltimore Maryland 21205 —
Washington University School of Medicine St Louis Missouri 63110 —
Mercury Street Medical Group Butte Montana 59701 —
Albany Medical Center Albany New York 12208 —
Montefiore Medical Center The Bronx New York 10467 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
The Miriam Hospital Providence Rhode Island 02906 —
Medical University of South Carolina Charleston South Carolina 29425 —
Dallas VA Medical Center Dallas Texas 75216 —
Parkland Hospital Dallas Texas 75235 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
South Texas Veterans Healthcare System San Antonio Texas 78229 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
University of Utah Hospitals and Clinics Salt Lake City Utah 84112 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02244606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02244606 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →